Recombinant Human SMAD9 Protein，His & GST

SMAD9, a member of the SMAD family of proteins, plays a crucial role in the transforming growth factor-beta (TGF-β) signaling pathway, which is essential for various cellular processes, including cell differentiation, proliferation, and apoptosis. Research into SMAD9 has gained significant interest due to its involvement in diverse physiological and pathological conditions, such as embryonic development, tissue homeostasis, and cancer progression. As a receptor-regulated SMAD, SMAD9 transmits signals from TGF-β receptors to the nucleus, where it regulates the expression of target genes. The study of SMAD9 recombinant proteins has become increasingly important for understanding the molecular mechanisms underlying these processes. By producing and characterizing SMAD9 in a recombinant form, researchers can investigate its functional properties, interactions with other signaling molecules, and its influence on downstream gene regulation. Furthermore, recombinant SMAD9 can be used as a valuable tool in drug discovery, allowing the identification of compounds that modulate its activity and potentially targeting TGF-β signaling pathways for therapeutic interventions. Given the complexity of TGF-β signaling and its implications in various diseases, the ongoing research on SMAD9 not only enhances our understanding of cell signaling but also paves the way for novel clinical applications in the treatment of cancer and fibrotic diseases.